Placeholder Content Image

Weight loss drug approved to treat sleep apnoea

<div class="theconversation-article-body"> <p>Last week, Australia’s <a href="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2023-PI-02114-1&amp;d=20250603172310101">Therapeutic Goods Administration</a> (TGA) approved <a href="https://www.afr.com/companies/healthcare-and-fitness/tga-approves-weight-loss-drug-to-treat-sleep-disorder-20250604-p5m4vq">the weight-loss drug Mounjaro</a> to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.</p> <p>The TGA has indicated Mounjaro can be used to treat moderate to severe obstructive sleep apnoea in adults with obesity (a body-mass index of 30 or above).</p> <p>The <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea">United States Food and Drug Administration</a> approved the same drug for sleep apnoea last year.</p> <p>So how could this drug, most commonly used for weight management and conditions such as type 2 diabetes, help people with sleep apnoea?</p> <h2>What is sleep apnoea?</h2> <p>Obstructive sleep apnoea is a common sleep disorder affecting almost <a href="https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(19)30198-5/abstract#:%7E:text=To%20our%20knowledge%2C%20this%20is,and%20to%20maximise%20cost%2Deffectiveness.">1 billion people</a> worldwide. It’s characterised by repeated closures of the airway during sleep (called “<a href="https://www.healthdirect.gov.au/obstructive-sleep-apnoea">apnoeas</a>”). These can be partial or complete closures, meaning breathing can become shallow or stop completely.</p> <p>As well as causing fragmented sleep, repeated collapse of the airway disrupts oxygen flow to the body. This strains the heart and contributes to an increased risk of <a href="https://www.sciencedirect.com/science/article/pii/S1875213620300413">cardiovascular and metabolic complications</a> <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11172971/">such as</a> diabetes, high blood pressure and stroke.</p> <p>One of the key risk factors for obstructive sleep apnoea is obesity. About <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9130173/">80% of people</a> with the condition live with obesity. In fact, obesity and sleep apnoea share a <a href="https://www.sciencedirect.com/science/article/pii/S0939475325001681">bidirectional relationship</a>, with obesity increasing the risk of developing sleep apnoea, and vice versa.</p> <p>Obesity increases the risk of sleep apnoea by adding fat around the neck, which narrows the airway and impacts breathing during sleep.</p> <p>In turn, sleep apnoea can contribute to weight gain by disrupting hormones that regulate hunger (ghrelin) and fullness signals (leptin). Fatigue also contributes, making it harder to maintain a healthy weight and easier to gain weight over time, creating <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5836788/">a vicious cycle</a> where each condition worsens the other.</p> <p>Weight loss is a key part of <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9059581/">treating sleep apnoea</a>. It helps reduce the severity of symptoms and also lowers the risk of heart disease and other health problems which may arise as a result of <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7874414/">sleep apnoea</a>. However, achieving and sustaining weight loss through lifestyle changes is often challenging.</p> <p>A continuous positive airway pressure (CPAP) machine is generally the <a href="https://www1.racgp.org.au/ajgp/2024/june/management-of-obstructive-sleep-apnoea-in-primary">first-line therapy</a> for managing moderate to severe sleep apnoea. It delivers a steady stream of pressurised air through a mask to keep the airway open during sleep, which stabilises breathing and improves sleep quality.</p> <p>Despite being an effective treatment, many people find the CPAP machine uncomfortable, unattractive or hard to use regularly. This can mean people don’t always <a href="https://pubmed.ncbi.nlm.nih.gov/30684472/">stick to it</a>.</p> <p>Given the significant human and <a href="https://pubmed.ncbi.nlm.nih.gov/34015136/">economic costs of sleep apnoea</a> it’s pertinent to keep exploring new prevention and management strategies.</p> <h2>What is Mounjaro, and how could it help people with sleep apnoea?</h2> <p>Mounjaro is the brand name of a drug called tirzepatide. Elsewhere, it goes by other brand names, such as Zepbound.</p> <p>Tirzepatide works by <a href="https://www.pnas.org/doi/full/10.1073/pnas.2116506119">mimicking two hormone receptors</a> in the gut, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).</p> <p>These <a href="https://www.sciencedirect.com/science/article/pii/S2212877818309001">two hormones</a> play a key role in regulating our appetite, food intake and blood sugar levels. GLP-1 and GIP are released naturally in the body when we eat, but by mimicking their effects, tirzepatide allows people to feel fuller with smaller meals.</p> <p>If a person is eating less overall, this can lead to weight loss.</p> <p>In <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2404881">a study of 469 people</a> with obesity and moderate to severe obstructive sleep apnoea, one year of tirzepatide treatment was associated with up to a 60% reduction in sleep apnoea severity. This is compared to a 3% reduction in people receiving a placebo.</p> <p>In addition, evidence shows tirzepatide is associated with improvements in <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11598664/pdf/nihms-2005020.pdf">several key health indicators</a>, including reduced systemic inflammation, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11972082/">enhanced insulin sensitivity</a> and lower blood pressure. Changes <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10157777/">such as these</a> may improve respiratory function and help protect against cardiovascular and metabolic complications, which are common outcomes of untreated sleep apnoea.</p> <h2>Are there any side effects?</h2> <p>While Mounjaro could be helpful for people with sleep apnoea, gastrointestinal <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10088547/pdf/jomes-32-1-25.pdf">side effects</a> are relatively common with this medication. These can include nausea, vomiting, diarrhoea, constipation and loss of appetite. These side effects typically go away as the person gets used to the medication.</p> <p>Some patients have also reported <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790392">gallbladder problems</a>.</p> <p>Despite these concerns, there is an <a href="https://assets.cureus.com/uploads/review_article/pdf/343603/20250405-83416-dhs9d8.pdf">interest in Mounjaro as sleep apnoea treatment</a> as it provides the first pharmaceutical option for a condition that has traditionally relied on mechanical treatments such as CPAP machines.</p> <p>That said, it’s important to note Mounjaro is indicated for use in patients with obesity, and <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9130173/">not all patients</a> with sleep apnoea are overweight or obese.</p> <p>In some <a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00153-1/fulltext?rss=yes">people of a healthy weight</a>, narrow skeletal structure or upper airway anatomy, such as larger soft palates (which can reduce airway space and make it more prone to collapse during sleep), could contribute to obstructive sleep apnoea.</p> <p>For those patients, non-pharmacological treatment options such as mandibular advancement devices (oral appliances that move the lower jaw forward and keep the airway open) and upper airway surgery may be needed to effectively manage the condition.</p> <p>Mounjaro is given as a weekly injection. In Australia, Mounjaro is not currently subsidised under the Pharmaceutical Benefits Scheme and is available only by private prescription, with prices beginning at around <a href="https://cosmeticclinic.net.au/mounjaro-australia-cost/#:%7E:text=On%20average%2C%20the%20cost%20of%20Mounjaro%20in%20Australia,the%20frequency%20of%20use%20and%20the%20required%20dosage.">A$395 per month</a>. The significant out-of-pocket cost will limit access to Mounjaro for many patients.</p> <p>Mounjaro’s approval for the treatment of sleep apnoea may offer new hope for many people. But considering the diversity in patient presentations and limited data from large population studies, it’s too early to say whether this will transform sleep apnoea care in Australia.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/258195/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em>By <a href="https://theconversation.com/profiles/yaqoot-fatima-2407464">Yaqoot Fatima</a>, Professor of Sleep Health, <a href="https://theconversation.com/institutions/university-of-the-sunshine-coast-1068">University of the Sunshine Coast</a> and <a href="https://theconversation.com/profiles/nisreen-aouira-2407465">Nisreen Aouira</a>, Research Program Manager, Thompson Institute, <a href="https://theconversation.com/institutions/university-of-the-sunshine-coast-1068">University of the Sunshine Coast</a></em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/the-weight-loss-drug-mounjaro-has-been-approved-to-treat-sleep-apnoea-how-does-it-work-258195">original article</a>.</em></p> </div>

Body

Placeholder Content Image

TGA approves new drug for Alzheimer’s

<div class="theconversation-article-body"> <p>This week, Australia’s <a href="https://www.tga.gov.au/resources/artg/420194">Therapeutic Goods Administration</a> (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.</p> <p>Donanemab has previously been approved in a number of other countries, including <a href="https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-adults-alzheimers-disease">the United States</a>.</p> <p>So what is donanemab, and who will be able to access it in Australia?</p> <blockquote class="twitter-tweet"> <p dir="ltr" lang="en">A drug that is given once a month to slow the cognitive decline associated with Alzheimer’s disease has been approved by the TGA, but will only be available for a select few who can afford it privately. <a href="https://t.co/sJqR3IKhAB">https://t.co/sJqR3IKhAB</a></p> <p>— ABC News (@abcnews) <a href="https://twitter.com/abcnews/status/1925378845135274425?ref_src=twsrc%5Etfw">May 22, 2025</a></p></blockquote> <h2>How does donanemab work?</h2> <p>There are more than 100 different causes <a href="https://www.alzint.org/about/dementia-facts-figures/types-of-dementia/">of dementia</a>, but Alzheimer’s disease alone accounts for about 70% of these, making it <a href="https://www.alzint.org/about/dementia-facts-figures/types-of-dementia/alzheimers-disease/">the most common form</a> of dementia.</p> <p>The disease is believed to be caused by the accumulation in the brain of two abnormal proteins, amyloid and tau. The first is thought to be particularly important, and the “<a href="https://theconversation.com/alzheimers-drug-donanemab-has-been-hailed-as-a-turning-point-for-treatment-but-what-does-it-mean-for-people-with-the-disease-209970">amyloid hypothesis</a>” – which suggests amyloid is the key cause of Alzheimer’s disease – has driven research for many years.</p> <p>Donanemab is a “monoclonal antibody” treatment. Antibodies are proteins the immune system produces that bind to harmful foreign “invaders” in the body, or targets. A monoclonal antibody has one specific target. In the case of donanemab it’s the amyloid protein. Donanemab binds to amyloid protein deposits (plaques) in the brain and allows our bodies to remove them.</p> <p>Donanemab is given monthly, via intravenous infusion.</p> <h2>What does the evidence say?</h2> <p>Australia’s approval of donanemab comes as a result of a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10352931/">clinical trial</a> involving 1,736 people published in 2023.</p> <p>This trial showed donanemab resulted in a significant slowing of disease progression in a group of patients who had either early Alzheimer’s disease, or mild cognitive impairment with signs of Alzheimer’s pathology. Before entering the trial, all patients had the presence of amyloid protein detected via <a href="https://www.healthdirect.gov.au/pet-scan">PET scanning</a>.</p> <p>Participants were randomised, and half received donanemab, while the other half received a placebo, over 18 months.</p> <p>For those who received the active drug, their Alzheimer’s disease progressed 35% more slowly over 18 months compared to those who were given the placebo. The researchers ascertained this using the <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4806404/">Integrated Alzheimer’s Disease Rating Scale</a>, which measures cognition and function.</p> <p>Those who received donanemab also demonstrated large reductions in the levels of amyloid in the brain (as measured by PET scans). The majority, by the end of the trial, were considered to be below the threshold that would normally indicate the presence of Alzheimer’s disease.</p> <p>These results certainly seem to vindicate the amyloid hypothesis, which had been <a href="https://pubmed.ncbi.nlm.nih.gov/33049114/">called into question</a> by the results of multiple <a href="https://www.wsj.com/articles/eli-lillys-alzheimers-drug-trial-fails-to-achieve-goals-1479902563">failed previous studies</a>. They represent a major advance in our understanding of the disease.</p> <p>That said, patients in the study did not <em>improve</em> in terms of cognition or function. They continued to decline, albeit at a significantly slower rate than those who were not treated.</p> <p>The actual clinical significance has been <a href="https://academic.oup.com/braincomms/article/6/6/fcae435/7915707">a topic of debate</a>. Some experts have questioned whether the meaningfulness of this result to the patient is worth the potential risks.</p> <h2>Is the drug safe?</h2> <p>Some 24% of trial participants receiving the drug experienced brain swelling. The rates rose to 40.6% in those possessing two copies of a gene called ApoE4.</p> <p>Although three-quarters of people who developed brain swelling experienced no symptoms from this, there were three deaths in the treatment group during the study related to donanemab, likely a result of brain swelling.</p> <p>These risks <a href="https://www.sciencedirect.com/science/article/pii/S2274580725000949">require regular monitoring</a> with MRI scans while the drug is being given.</p> <p>Some 26.8% of those who received donanemab also experienced small bleeds into the brain (microhaemorrhages) compared to 12.5% of those taking the placebo.</p> <h2>Cost is a barrier</h2> <p>Reports indicate donanemab could cost anywhere between <a href="https://www.abc.net.au/news/2025-05-22/alzheimers-drug-donanemab-tga-approval-dementia/105319856">A$40,000 and $80,000</a> each year in Australia. This puts it beyond the reach of many who might benefit from it.</p> <p>Eli Lilly, the manufacturer of donanemab, has made an application for the drug to be listed on the Pharmaceutical Benefits Scheme, with a decision pending perhaps within <a href="https://www.abc.net.au/news/2025-05-22/alzheimers-drug-donanemab-tga-approval-dementia/105319856">a couple of months</a>. While this would make the drug substantially more affordable for patients, it will represent a large cost to taxpayers.</p> <p>The cost of the drug is in addition to costs associated with the monitoring required to ensure its safety and efficacy (such as doctor visits, MRIs and PET scans).</p> <h2>Who will be able to access it?</h2> <p>This drug is only of benefit for people with early Alzheimer’s-type dementia, so not everybody with Alzheimer’s disease will get access to it.</p> <p>Almost 80% of people who were screened to participate <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10352931/">in the trial</a> were found unsuitable to proceed.</p> <p>The terms of the <a href="https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&amp;docid=420194&amp;agid=%28PrintDetailsPublic%29&amp;actionid=1">TGA approval</a> specify potential patients will first need to be found to have specific levels of amyloid protein in their brains. This would be ascertained either by PET scanning or by lumbar puncture sampling of spinal fluid.</p> <p>Also, patients with two copies of the ApoE4 gene have been ruled unsuitable to receive the drug. The TGA has judged the risk/benefit profile for this group to be unfavourable. This genetic profile accounts for only 2% of the general population, but <a href="https://www.nih.gov/news-events/nih-research-matters/study-defines-major-genetic-form-alzheimer-s-disease">15% of people with Alzheimer’s disease</a>.</p> <h2>Improving diagnosis and tempering expectations</h2> <p>It’s estimated more than <a href="https://www.aihw.gov.au/reports/dementia/dementia-in-aus/contents/population-health-impacts-of-dementia/prevalence-of-dementia">400,000 Australians</a> have dementia. But only <a href="https://www.aihw.gov.au/reports/dementia/ndap-indicators-dashboard/contents/action-4/measure-4-5-time-from-symptom-onset-to-diagnosis">13% of people</a> with dementia currently receive a diagnosis within a year of developing symptoms.</p> <p>Given those with very early disease stand to benefit most from this treatment, we need to expand our dementia diagnostic services significantly.</p> <p>Finally, expectations need to be tempered about what this drug can reasonably achieve. It’s important to be mindful this is not a cure.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/257321/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em>By <a href="https://theconversation.com/profiles/steve-macfarlane-4722">Steve Macfarlane</a>, Head of Clinical Services, Dementia Support Australia, &amp; Associate Professor of Psychiatry, <a href="https://theconversation.com/institutions/monash-university-1065">Monash University</a></em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/the-tga-has-approved-donanemab-for-alzheimers-disease-how-does-this-drug-work-and-who-will-be-able-to-access-it-257321">original article</a>.</em></p> </div>

Caring

Placeholder Content Image

Do any non-drug treatments help back pain? Here’s what the evidence says

<div class="theconversation-article-body"> <p>Jason, a 42-year-old father of two, has been battling back pain for weeks. Scrolling through his phone, he sees ad after ad promising relief: chiropractic alignments, acupuncture, back braces, vibrating massage guns and herbal patches.</p> <p>His GP told him to “stay active”, but what does that even mean when every movement hurts? Jason wants to avoid strong painkillers and surgery, but with so many options (and opinions), it’s hard to know what works and what’s just marketing hype.</p> <p>If Jason’s experience sounds familiar, you’re not alone. Back pain is one of the most common reasons people visit a doctor. It can be challenging to manage, mainly due to widespread <a href="https://theconversation.com/having-good-posture-doesnt-prevent-back-pain-and-bad-posture-doesnt-cause-it-183732">misunderstandings</a> and the <a href="https://ebm.bmj.com/content/early/2025/03/02/bmjebm-2024-112974">overwhelming number</a> of ineffective and uncertain treatments promoted.</p> <p>We assessed the best available evidence of non-drug and non-surgical treatments to alleviate low back pain. <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014691.pub2/full">Our review</a> – published today by the independent, international group the Cochrane Collaboration – includes 31 Cochrane systematic reviews, covering 97,000 people with back pain.</p> <p>It <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014691.pub2/full">shows</a> bed rest doesn’t work for back pain. Some of the treatments that do work can depend on how long you’ve been in pain.</p> <h2>Is back pain likely to be serious?</h2> <p>There are different types of low back pain. It can:</p> <ul> <li>be short-lived, lasting less than six weeks (acute back pain)</li> <li>linger for a bit longer, for six to twelve weeks (sub-acute)</li> <li>stick around for months and even years (chronic, defined as more than 12 weeks).</li> </ul> <p>In <a href="https://www.thelancet.com/article/S0140-6736(16)30970-9/abstract">most cases</a> (90-95%), back pain is non-specific and cannot be reliably linked to a specific cause or underlying disease. This includes common structural changes seen in x-rays and MRIs of the spine.</p> <p>For this reason, imaging of the back is <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60172-0/abstract">only</a> recommended in rare situations – typically when there’s a clear suspicion of serious back issues, such as after physical trauma or when there is numbness or loss of sensation in the groin or legs.</p> <p>Many people expect to receive <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013815.pub2/full">painkillers</a> for their back pain or even surgery, but these are no longer the front-line treatment options due to limited benefits and the high risk of harm.</p> <p>International <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30489-6/fulltext">clinical guidelines</a> recommend people choose non-drug and non-surgical treatments to relieve their pain, improve function and reduce the distress commonly associated with back pain.</p> <p>So what works for different types of pain? Here’s what <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014691.pub2/full">our review found</a> when researchers compared these treatments with standard care (the typical treatment patients usually receive) or no treatment.</p> <h2>What helps for short-term back pain</h2> <p><strong>1. Stay active – don’t rest in bed</strong></p> <p>If your back pain is new, the best advice is also one of the simplest: keep moving despite the pain.</p> <p>Changing the way you move and use your body to protect it, or resting in bed, can seem like to right way to respond to pain – and may have even been recommended in the past. But we know know this excessive protective behaviour can make it harder to return to meaningful activities.</p> <p>This doesn’t mean pushing through pain or hitting the gym, but instead, trying to maintain your usual routines as much as possible. Evidence suggests that doing so won’t make your pain worse, and may improve it.</p> <p><strong>2. Multidisciplinary care, if pain lingers</strong></p> <p>For pain lasting six to 12 weeks, multidisciplinary treatment is likely to reduce pain compared to standard care.</p> <p>This involves a coordinated team of doctors, physiotherapists and psychologists working together to address the many factors contributing to your back pain persisting:</p> <ul> <li> <p>neurophysiological influences refer to how your nervous system is currently processing pain. It can make you more sensitive to signals from movements, thoughts, feelings and environment</p> </li> <li> <p>psychological factors include how your thoughts, feelings and behaviours affect your pain system and, ultimately, the experience of pain you have</p> </li> <li> <p>occupational factors include the physical demands of your job and how well you can manage them, as well as aspects like low job satisfaction, all of which can contribute to ongoing pain.</p> </li> </ul> <h2>What works for chronic back pain</h2> <p>Once pain has been around for more than 12 weeks, it can become more difficult to treat. But relief is still possible.</p> <p><strong>Exercise therapy</strong></p> <p>Exercise – especially programs tailored to your needs and preferences – is likely to reduce pain and help you move better. This could include aerobic activity, strength training or Pilates-based movements.</p> <p>It doesn’t seem to matter what type of exercise you do – it matters more that you are consistent and have the right level of supervision, especially early on.</p> <p><strong>Multidisciplinary treatment</strong></p> <p>As with short-term pain, coordinated care involving a mix of physical, occupational and psychological approaches likely works better than usual care alone.</p> <p><strong>Psychological therapies</strong></p> <p>Psychological therapies for chronic pain include approaches to help people change thinking, feelings, behaviours and reactions that might sustain persistent pain.</p> <p>These approaches are likely to reduce pain, though they may not be as effective in improving physical function.</p> <p><strong>Acupuncture</strong></p> <p>Acupuncture probably reduces pain and improves how well you can function compared to placebo or no treatment.</p> <p>While some debate remains about how it works, the evidence suggests potential benefits for some people with chronic back pain.</p> <h2>What doesn’t work or still raises uncertainty?</h2> <p>The review found that many commonly advertised treatments still have uncertain benefits or probably do not benefit people with back pain.</p> <p>Spinal manipulation, for example, has uncertain benefits in acute and chronic back pain, and it likely does not improve how well you function if you have acute back pain.</p> <p>Traction, which involves stretching the spine using weights or pulleys, probably doesn’t help with chronic back pain. Despite its popularity in some circles, there’s little evidence that it works.</p> <p>There isn’t enough reliable data to determine whether advertised treatments – such back braces, vibrating massage guns and herbal patches – are effective.</p> <h2>How can you use the findings?</h2> <p>If you have back pain, start by considering how long you’ve had it. Then explore treatment options that research supports and discuss them with your GP, psychologist or physiotherapist.</p> <p>Your health provider should reassure you about the importance of gradually increasing your activity to resume meaningful work, social and life activities. They should also support you in making informed decisions about which treatments are most appropriate for you at this stage.</p> <p><!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><em><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/253122/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" />By <a href="https://theconversation.com/profiles/rodrigo-rossi-nogueira-rizzo-1544189">Rodrigo Rossi Nogueira Rizzo</a>, Postdoctoral Research Fellow, <a href="https://theconversation.com/institutions/neuroscience-research-australia-976">Neuroscience Research Australia</a> and <a href="https://theconversation.com/profiles/aidan-cashin-2355450">Aidan Cashin</a>, NHMRC Emerging Leadership Fellow, <a href="https://theconversation.com/institutions/neuroscience-research-australia-976">Neuroscience Research Australia</a></em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/do-any-non-drug-treatments-help-back-pain-heres-what-the-evidence-says-253122">original article</a>.</em></p> <p><em>Image: Shutterstock</em></p> </div>

Body

Placeholder Content Image

Olympic champion breaks down over drug scandal

<p>Olympic swimming champion Shayna Jack has broken down over the drug scandal that almost ended her career in 2019. </p> <p>After entering the jungle as one of this year's <em>I'm A Celebrity... Get Me Out of Here!</em> cast mates, Paris Olympics gold medallist Jack opened up about the 24-month ban she copped from her sport in 2019.</p> <p>She was banned for competing for two long years, for an anti-doping rule violation relating to her unintentional use of the anabolic agent Ligandrol. </p> <p>Jack then spent months embroiled in a case to prove her innocence in which she spent over $180,000, with the case putting her under intense emotional and financial strain. </p> <p>Jack broke down as she revealed to her campmates that her longtime partner, Kookaburras hockey player Joel Rintala, was scared to leave her at home alone for fear she might hurt herself. </p> <p>“Some nights I was in a bad place. He said those nights were the most fearful. He said he’d speed home because he just didn’t know if he was going to walk home into something that he wasn’t able to cope with. [If] I’d done something that I would eternally regret,” she said.</p> <p>Speaking directly to camera in the jungle's confessional, Jack went on to explain why she chose to share the story with her fellow cast members. </p> <p>“It’s using the people around me to continue to open up about it and face those difficulties and stop giving it so much power,” she said of the scandal. </p> <p>“I feel like the more I take it off my chest and take it off my heart, the more I can try to move forward with my life and not feel this huge aspect of my life pulling me back."</p> <p><em>Image credits: Ten</em></p>

Legal

Placeholder Content Image

Andrew O'Keefe faces more drug charges

<p>Troubled former TV host Andrew O'Keefe has once again faced court over allegations of driving under the influence of drugs. </p> <p>Andrew O’Keefe, 53, was stopped at 11:30am on July 28th for random testing while driving his Mercedes in Rose Bay, in Sydney’s eastern suburbs.</p> <p>Police say he recorded a positive result for the roadside drug test, while he returned a negative result for the roadside breath test.</p> <p>The former <em>Deal or No Deal</em> host was taken to Waverley Police Station where he underwent a second oral fluid test that returned another positive reading.</p> <p>He was charged with driving a vehicle with an illicit drug present in his system.</p> <p>The former host of The Chase was represented by his lawyer Jahan Kalantar in Waverley Local Court on Monday, where Magistrate Stephen Barlow adjourned the matter until early next month.</p> <p>O’Keefe will remain out on bail.</p> <p>The new charge comes after O’Keefe received a 30-month community corrections order and $2,500 in fines after pleading guilty to drug-related offences in October last year.</p> <p><em>Image credits: Channel Seven</em></p> <p style="box-sizing: inherit; border: 0px; font-stretch: inherit; line-height: inherit; font-family: 'Helvetica Neue', HelveticaNeue, Helvetica, Arial, sans-serif; font-size-adjust: inherit; font-kerning: inherit; font-variant-alternates: inherit; font-variant-ligatures: inherit; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-variant-position: inherit; font-feature-settings: inherit; font-optical-sizing: inherit; font-variation-settings: inherit; font-size: 18px; margin: 0px 0px 24px; padding: 0px; vertical-align: baseline;"> </p>

Legal

Placeholder Content Image

Aussie grandmother found guilty of importing drugs into Japan

<p>Australian grandmother Donna Nelson has been found guilty of importing two kilograms of methamphetamine into Japan, despite her claims that she was the victim of an online scam.</p> <p>The 58-year-old was convicted of the crime by a panel of three professional judges and six members of the public in a decision delivered in Chiba, Tokyo on Wednesday. </p> <p>She has been sentenced to six years in jail, with the 430 days she has already served to be deducted from her time behind bars and she was also fined $10,400.</p> <p>Nelson and her team have two weeks to launch their likely appeal. </p> <p>“I believe this is a very unreasonable decision. We need to talk with Donna but we will fight until the end, until she gets freedom,” her lawyer Rie Nishida said outside the court.</p> <p>“She’s devastated but she’s a strong woman so we will discuss and prepare for the next fight.”</p> <p>Nelson, a prominent Indigenous leader, has maintained her innocence and told the court last month she had no idea the drugs had been hidden in her luggage by a man she thought was her boyfriend. </p> <p>She picked up the travel bag during a three-stop in Laos and claimed she had been tricked into believing it was a sample case he needed for his fashion business in Japan. </p> <p>Nelson started her online romance in 2020, and after several failed attempts to meet in person, her love interest bought her a flight ticket to Japan, which included the Laos stop where an acquaintance of his delivered the bag. </p> <p>She was supposed to meet up with the man in Japan but he never showed, according to prosecutors.</p> <p>Nelson was arrested at Tokyo's Narita Airport in January 2023, and later charged with violating the stimulants control and customs laws.</p> <p>Prosecutors acknowledged the case is linked to a romance scam but accused Nelson of smuggling the drugs, claiming she knew the contents of the suitcase. </p> <p>Nelson's daughters hoped the years of messages between Nelson and the romance scammer would show the court she had no idea about the meth, but the court ruled that she ignored too many red flags about the man she had met online and she should've been suspicious enough to not carry the suitcase for him. </p> <p>The judges said they accepted she was deceived and sympathised with her, so she received a lighter sentence than others given for the same offence. </p> <p>Prosecutors in Japan had initially asked for her to be thrown in jail for 20 years and fined $31,000 if found guilty. </p> <p>Outside court, Nelson's daughter Kristal Hilaire said six years in a Japanese prison away from home and family was in no way a “lenient” sentence.</p> <p>Her loved ones have also launched a GoFundMe to “free our mum and bring her home, where (she) belongs”.</p> <p>They stated that their “beloved” mother “was duped by her partner into carrying a bag into Japan which contained drugs”.</p> <p>“Our Mum had no knowledge of this, and we maintain that she is a victim of a crime and not a criminal,” they continued.</p> <p><em>Image: 7News</em></p>

Legal

Placeholder Content Image

New study suggests weight loss drugs like Ozempic could help with knee pain. Here’s why there may be a link

<div class="theconversation-article-body"> <p><em><a href="https://theconversation.com/profiles/giovanni-e-ferreira-1030477">Giovanni E. Ferreira</a>, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a> and <a href="https://theconversation.com/profiles/christina-abdel-shaheed-425241">Christina Abdel Shaheed</a>, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a></em></p> <p>The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was <a href="https://theconversation.com/the-rise-of-ozempic-how-surprise-discoveries-and-lizard-venom-led-to-a-new-class-of-weight-loss-drugs-219721">originally developed</a> to help people with type 2 diabetes manage their blood sugar levels.</p> <p>However, researchers have discovered it may help with other health issues, too. Clinical trials show semaglutide can be effective for <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183">weight loss</a>, and hundreds of thousands of people around the world are using it <a href="https://theconversation.com/considering-taking-a-weight-loss-drug-like-ozempic-here-are-some-potential-risks-and-benefits-219312">for this purpose</a>.</p> <p>Evidence has also shown the drug can help manage <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2306963">heart failure</a> and <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2403347">chronic kidney disease</a> in people with obesity and type 2 diabetes.</p> <p>Now, a study published in the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2403664">New England Journal of Medicine</a> has suggested semaglutide can improve knee pain in people with obesity and osteoarthritis. So what did this study find, and how could semaglutide and osteoarthritis pain be linked?</p> <h2>Osteoarthritis and obesity</h2> <p>Osteoarthritis is a common joint disease, affecting <a href="https://www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/osteoarthritis">2.1 million Australians</a>. Most people with osteoarthritis <a href="https://theconversation.com/do-you-have-knee-pain-from-osteoarthritis-you-might-not-need-surgery-heres-what-to-try-instead-236779">have pain</a> and find it difficult to perform common daily activities such as walking. The knee is <a href="https://pubmed.ncbi.nlm.nih.gov/37675071/">the joint most commonly affected</a> by osteoarthritis.</p> <p>Being overweight or obese is a <a href="https://pubmed.ncbi.nlm.nih.gov/25447976/">major risk factor</a> for osteoarthritis in the knee. The link between the two conditions <a href="https://pubmed.ncbi.nlm.nih.gov/26821091/">is complex</a>. It involves a combination of increased load on the knee, <a href="https://www.nature.com/articles/s41413-023-00301-9">metabolic factors</a> such as high cholesterol and high blood sugar, and inflammation.</p> <p>For example, elevated blood sugar levels increase the production of inflammatory molecules in the body, which can damage the cartilage in the knee, and lead to the <a href="https://pubmed.ncbi.nlm.nih.gov/30712918/">development of osteoarthritis</a>.</p> <p>Weight loss is strongly recommended to reduce the pain of knee osteoarthritis in people who are overweight or obese. <a href="https://pubmed.ncbi.nlm.nih.gov/31908149/">International</a> and <a href="https://www.safetyandquality.gov.au/sites/default/files/2024-08/osteoarthritis-knee-clinical-care-standard-2024.pdf">Australian guidelines</a> suggest losing as little as 5% of body weight can help.</p> <p>But losing weight with just diet and exercise can be difficult for many people. <a href="https://pubmed.ncbi.nlm.nih.gov/26180980/">One study</a> from the United Kingdom found the annual probability of people with obesity losing 5% or more of their body weight was less than one in ten.</p> <p>Semaglutide has recently entered the market as a potential alternative route to weight loss. It comes from a class of drugs known as GLP-1 receptor agonists and works by increasing a person’s sense of fullness.</p> <h2>Semaglutide for osteoarthritis?</h2> <p>The rationale for the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2403664">recent study</a> was that while we know weight loss alleviates symptoms of knee osteoarthritis, the effect of GLP-1 receptor agonists was yet to be explored. So the researchers set out to understand what effect semaglutide might have on knee osteoarthritis pain, alongside body weight.</p> <p>They randomly allocated 407 people with obesity and moderate osteoarthritis into one of two groups. One group received semaglutide once a week, while the other group received a placebo. Both groups were treated for 68 weeks and received counselling on diet and physical activity. At the end of the treatment phase, researchers measured changes in knee pain, function, and body weight.</p> <p>As expected, those taking semaglutide lost more weight than those in the placebo group. People on semaglutide lost around 13% of their body weight on average, while those taking the placebo lost around 3% on average. More than 70% of people in the semaglutide group lost at least 10% of their body weight compared to just over 9% of people in the placebo group.</p> <p>The study found semaglutide reduced knee pain significantly more than the placebo. Participants who took semaglutide reported an additional 14-point reduction in pain on a 0–100 scale compared to the placebo group.</p> <p>This is much greater than the pain reduction in another <a href="https://pubmed.ncbi.nlm.nih.gov/36511925/">recent study</a> among people with obesity and knee osteoarthritis. This study investigated the effects of a diet and exercise program compared to an attention control (where participants are provided with information about nutrition and physical activity). The results here saw only a 3-point difference between the intervention group and the control group on the same scale.</p> <p>The amount of pain relief reported in the semaglutide trial is also larger than that reported with commonly used pain medicines such as <a href="https://pubmed.ncbi.nlm.nih.gov/35442752/">anti-inflammatories</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/35137418/">opioids</a> and <a href="https://www.bmj.com/content/372/bmj.m4825">antidepressants</a>.</p> <p>Semaglutide also improved knee function compared to the placebo. For example, people who took semaglutide could walk about 42 meters further than those on the placebo in a six-minute walking test.</p> <h2>How could semaglutide reduce knee pain?</h2> <p>It’s not fully clear how semaglutide helps with knee pain from osteoarthritis. One explanation may be that when a person loses weight, there’s less stress on the joints, which reduces pain.</p> <p>But recent studies have also suggested semaglutide and other GLP-1 receptor agonists might have <a href="https://www.sciencedirect.com/science/article/pii/S1043661822002651">anti-inflammatory</a> properties, and could even protect against <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6731440/">cartilage wear and tear</a>.</p> <p>While the results of this new study are promising, it’s too soon to regard semaglutide as a “miracle drug” for knee osteoarthritis. And as this study was funded by the drug company that makes semaglutide, it will be important to have independent studies in the future, to confirm the findings, or not.</p> <p>The study also had strict criteria, excluding some groups, such as those taking opioids for knee pain. One in seven Australians seeing a GP for their knee osteoarthritis <a href="https://pubmed.ncbi.nlm.nih.gov/34527976/">are prescribed opioids</a>. Most participants in the trial were white (61%) and women (82%). This means the study may not fully represent the average person with knee osteoarthritis and obesity.</p> <p>It’s also important to consider semaglutide can have a range of <a href="https://theconversation.com/considering-taking-a-weight-loss-drug-like-ozempic-here-are-some-potential-risks-and-benefits-219312">side effects</a>, including gastrointestinal symptoms and fatigue.</p> <p>There are some concerns that semaglutide could reduce <a href="https://www.sciencealert.com/experts-are-concerned-drugs-like-ozempic-may-cause-muscle-loss">muscle mass</a> and <a href="https://www.healthline.com/health-news/ozempic-muscle-mass-loss">bone density</a>, though we’re still learning more about this.</p> <p>Further, it can be difficult to access.</p> <h2>I have knee osteoarthritis, what should I do?</h2> <p>Osteoarthritis is a disease caused by multiple factors, and it’s important to take <a href="https://www.safetyandquality.gov.au/standards/clinical-care-standards/osteoarthritis-knee-clinical-care-standard/information-consumers-osteoarthritis-knee-clinical-care-standard">a multifaceted approach</a> to managing it. Weight loss is an important component for those who are overweight or obese, but so are other aspects of <a href="https://theconversation.com/do-you-have-knee-pain-from-osteoarthritis-you-might-not-need-surgery-heres-what-to-try-instead-236779">self-management</a>. This might include physical activity, pacing strategies, and other positive lifestyle changes such as improving sleep, healthy eating, and so on.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/243159/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em><a href="https://theconversation.com/profiles/giovanni-e-ferreira-1030477">Giovanni E. Ferreira</a>, NHMRC Emerging Leader Research Fellow, Institute of Musculoskeletal Health, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a> and <a href="https://theconversation.com/profiles/christina-abdel-shaheed-425241">Christina Abdel Shaheed</a>, Associate Professor, School of Public Health, <a href="https://theconversation.com/institutions/university-of-sydney-841">University of Sydney</a></em></p> <p><em>Image credits: Shutterstocl</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/new-study-suggests-weight-loss-drugs-like-ozempic-could-help-with-knee-pain-heres-why-there-may-be-a-link-243159">original article</a>.</em></p> </div>

Body

Placeholder Content Image

Aussie rocker hits back at John Farnham's drugging claims

<p>A legendary Australian rockstar has hit back at John Farnham's claims that he was <a href="https://oversixty.com.au/health/caring/so-ashamed-john-farnham-opens-up-about-years-of-abuse" target="_blank" rel="noopener">drugged</a> by a former manager. </p> <p>Peter Tilbrook, who was the guitarist for iconic Aussie rock band The Masters Apprentices in the 1960s, has taken to social media to share his own stories about Darryl Sambell, after Farnham wrote in his memoir that Samuel drugged him in the early days of his career. </p> <p>As Farnham wrote in <em>The Voice Inside</em>, he recalled that Sambell “drugged me for years and I had no f**king idea,” until he found a half-dissolved pill at the bottom of a cup of coffee. </p> <p>Asked what it was, Sambell told Farnham: “That’s just something to keep you awake.”</p> <p>However, Tilbrook took aim at the comments saying he also worked with Sambell and only had good experiences.</p> <p>"Sambell was a brilliant and skilful manager to us, and from what we saw and heard, definitely to Farnham as well," Tilbrook said online.</p> <p>"I find it very hard to believe that any another manager at the time could have done any more to further Johnny's incredible career."</p> <p>Sambell, who managed Farnham's early career from 1967 to 1976, also managed The Masters around the same time, and Tilbrook asserted his experience with the late manager was nothing like Farnham's.</p> <p>"He was an amazing, caring and resourceful manager," Tilbrook said. </p> <p><em>Image credits: petertilbrookentertainment.com/news.com.au</em></p> <p> </p>

Legal

Placeholder Content Image

Disgraced Olympian sentenced over failed drug plot

<p>An Olympic silver medallist and his younger brother, who tried to smuggle hundreds of kilograms of cocaine worth about $200 million into Australia, have been sentenced a second time. </p> <p>Nathan Baggaley, 48, a former champion kayaker and his brother Dru Baggaley, 42, faced Brisbane supreme court on Monday after pleading guilty to attempting to import a commercial quantity of drugs.</p> <p>Dru and another man were intercepted by the navy in July 2017, after he was found using a seven-metre inflatable boat to pick up 650 kilograms of cocaine from a ship near Australia's east coast. </p> <p>The inflatable boat, which was launched from Brunswick Heads on the NSW north coast, had been bought by Nathan and was registered in his name. </p> <p><span style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;">The brothers were previously found guilty of </span>attempting to import cocaine by a Brisbane Supreme Court jury in April 2021. </p> <p>Nathan was sentenced to 25 years' imprisonment and his brother 28 years, but they later won appeals against their convictions and were ordered to face the retrial that was supposed to start on October 28, but instead pleaded guilty to the same charge.</p> <p>On Monday, Justice Declan Kelly sentenced Nathan to 13 years in jail and his brother 15 years. </p> <p>With time already served, they are now eligible for parole. </p> <p>During their sentencing hearing, Justice Kelly said there was insufficient evidence to prove Dru knew he was importing cocaine, after the court was told he thought he was collecting tobacco. </p> <p>“Dru was reckless that there was a substantial quantity of a border-controlled drug but there is insufficient evidence that he knew the precise quantity,” Justice Kelly said.</p> <p>He said that Nathan didn't initially know that it was an attempt to import a border-controlled drug until July 30 2018. </p> <p>"From that point in time he was aware of the attempt to import a substantial quantity of a border-controlled drug but was reckless as to the identity of that drug," Justice Kelly said.</p> <p>“It cannot be shown that Nathan knew the drug was cocaine or the precise amount of the drug.”</p> <p>Kelly accepted a defence barrister's submission the facts were profoundly different” compared to their 2021 sentencing, but said that regardless, the importation size was a "“very relevant factor” in his sentencing.</p> <p><em>Image: Erik S Lesser/EPA/ Shutterstock Editorial</em></p>

Legal

Placeholder Content Image

Tearful Jackie O reveals past drug addiction

<p>Jackie O Henderson has revealed her private battle with drug addiction that resulted in a stint in rehab. </p> <p>On her KIIS FM radio show with Kyle Sandilands, Jackie O read an excerpt from her autobiography <em>The Whole Truth</em>, that is set to his shelves on October 29th, detailing her struggles with addiction two years ago.</p> <p>Henderson said she was “badly addicted” to painkillers, sleeping pills and consuming alcohol for three years, before checking herself in for a month-long stay at the Betty Ford Centre in Palm Springs, California, in November 2022. </p> <p>The radio host said she was feeling “so nervous” to read out the excerpt, as it was “something I haven’t been very forthcoming about or very truthful about”, recalling how she was feeling “diminished, untethered and alone”.</p> <p>“By that point, I had no self-esteem, so I was insecure, vulnerable, and heartbroken,” she read.</p> <p>“It was a recipe for disaster, and I took the coward’s way out to escape those feelings.”</p> <blockquote class="instagram-media" style="background: #FFF; border: 0; border-radius: 3px; box-shadow: 0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width: 540px; min-width: 326px; padding: 0; width: calc(100% - 2px);" data-instgrm-permalink="https://www.instagram.com/reel/DBfJRIoSaRz/?utm_source=ig_embed&amp;utm_campaign=loading" data-instgrm-version="14"> <div style="padding: 16px;"> <div style="display: flex; flex-direction: row; align-items: center;"> <div style="background-color: #f4f4f4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;"> </div> <div style="display: flex; flex-direction: column; flex-grow: 1; justify-content: center;"> <div style="background-color: #f4f4f4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;"> </div> <div style="background-color: #f4f4f4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;"> </div> </div> </div> <div style="padding: 19% 0;"> </div> <div style="display: block; height: 50px; margin: 0 auto 12px; width: 50px;"> </div> <div style="padding-top: 8px;"> <div style="color: #3897f0; font-family: Arial,sans-serif; font-size: 14px; font-style: normal; font-weight: 550; line-height: 18px;">View this post on Instagram</div> </div> <div style="padding: 12.5% 0;"> </div> <div style="display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;"> <div> <div style="background-color: #f4f4f4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);"> </div> <div style="background-color: #f4f4f4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;"> </div> <div style="background-color: #f4f4f4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);"> </div> </div> <div style="margin-left: 8px;"> <div style="background-color: #f4f4f4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;"> </div> <div style="width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg);"> </div> </div> <div style="margin-left: auto;"> <div style="width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);"> </div> <div style="background-color: #f4f4f4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);"> </div> <div style="width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);"> </div> </div> </div> <div style="display: flex; flex-direction: column; flex-grow: 1; justify-content: center; margin-bottom: 24px;"> <div style="background-color: #f4f4f4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 224px;"> </div> <div style="background-color: #f4f4f4; border-radius: 4px; flex-grow: 0; height: 14px; width: 144px;"> </div> </div> <p style="color: #c9c8cd; font-family: Arial,sans-serif; font-size: 14px; line-height: 17px; margin-bottom: 0; margin-top: 8px; overflow: hidden; padding: 8px 0 7px; text-align: center; text-overflow: ellipsis; white-space: nowrap;"><a style="color: #c9c8cd; font-family: Arial,sans-serif; font-size: 14px; font-style: normal; font-weight: normal; line-height: 17px; text-decoration: none;" href="https://www.instagram.com/reel/DBfJRIoSaRz/?utm_source=ig_embed&amp;utm_campaign=loading" target="_blank" rel="noopener">A post shared by Kyle and Jackie O (@kyleandjackieo)</a></p> </div> </blockquote> <p>Jackie admitted that it was only a small circle of friends who knew about her addiction, with Sandilands saying he was oblivious to his co-host's struggles. </p> <p>“I just didn’t want anyone to know until I had at least gotten a year or more of sobriety under my belt,” Henderson said.</p> <p>“I can only speak to my experience because my addiction is so different to anyone else’s."</p> <p>“But people can ask me anything they want, and I’m OK with that. I brought this up, I put it out there myself, so I’m well and truly OK talking about it. I’m excited that I can be more authentic than I’ve ever been.”</p> <p>She went on to recall how before she flew to America for rehab, she told her audience that she was taking time off for the end of the year. </p> <p>“But I know I won’t make it that far, I’m hanging on by a thread,” she read from her book.</p> <p>“There’s only one thing to do today, get on a plane for Los Angeles. My best friend and manager Gemma O’Neill is with me … she tells me I won’t need any fancy dresses where I’m going.”</p> <p>Henderson recalled grabbing lunch with O’Neill the day of their flight and being “teary”, adding, "Not because I don’t want to go on this journey but because I don’t have the faintest idea what it will be like and that scares me.”</p> <p>At the Betty Ford Centre, she was enrolled in a 28-day, 12-step program to “treat the substance dependence and drug addiction I’ve been able to keep secret for three long and painful years”.</p> <p>The 49-year-old said there were “lots of different reasons” for her addiction, but did not go into any on-air.</p> <p>Henderson said she went back and forth about whether to share her story but decided to make it public, “to use my story to help people”.</p> <p>She ended the emotional segment by sharing her gratitude that the story had never previously emerged and she was soon to celebrate her two-year sobriety milestone.</p> <p>“My life has changed for the better and I’m really, really thankful that I did it,” she said.</p> <p><em>Image credits: Instagram </em></p>

Caring

Placeholder Content Image

"Time for a rest": John Laws retires from radio

<p>Radio veteran John Laws has announced his plans to retire from radio in the coming weeks. </p> <p>The radio host, 89, shocked his loyal listeners on his 2SM show on Tuesday morning, after reading out a letter from a fan who wrote how much they enjoy listening to the show each day. </p> <p>“You’re not going to be hearing it for long, mate,” Laws said in response to the email. “I think it’s time for a rest.</p> <p>“I’ve done it for a very, very, very, very long time,” Laws said about his broadcasting career. “And I think that I’ll just call it a day, and call it a day pretty soon.”</p> <p>Laws said that he will “probably” hang up his headphones at the beginning of November when he celebrates 71 years on air.</p> <p>“I don’t want to be greedy,” he said. “I’ve had 71 fantastic years … and loved almost every minute of it.”</p> <p>He also made clear that after his final show, he will not be returning to radio. </p> <p>“I’m not going to go away and then come back again and say, ‘oh, it was all a mistake,’” he said on 2SM. “It may well be a mistake, but there’ll be no return. That’s it.”</p> <p>Laws then outlined his plans for his long-awaited retirement, saying, “I’ll travel, I’ll sit about, I’ll read more… and I’ll catch up with things that I should have caught up with a long time ago”.</p> <p>The retirement announcement came as a shock to many loyal viewers, as Laws said in an interview in 2023 that he can't picture himself ever stepping back from the coveted radio role. </p> <p>Just last year he told <em><a href="https://www.dailytelegraph.com.au/entertainment/sydney-confidential/john-laws-reveals-he-doesnt-think-about-retirement-as-he-notches-up-70-years-in-radio/news-story/9ed6d8dad7af5523e6c70bca45f8516d" target="_blank" rel="noopener" data-tgev="event119" data-tgev-container="bodylink" data-tgev-order="9ed6d8dad7af5523e6c70bca45f8516d" data-tgev-label="entertainment" data-tgev-metric="ev">The Daily Telegraph</a></em>, “I don’t think about retirement. I suppose I will have to one day but no, I don’t want to stop, I’d like to be doing it when I am 100.”</p> <p><em>Image credits: 9News / 2SM </em></p>

Retirement Life

Placeholder Content Image

"20 years to life": Bali's brutal new law

<p>Major changers are coming into effect for foreigners in Bali. </p> <p>Indonesia's Department of Immigration has doubled down on its zero-tolerance approach to unruly tourists, as those found in breach of immigration laws or have overstayed their visas could be sentenced to life behind bars. </p> <p>Crimes that were previously punishable with sentences from six months to one year in prison are increasing to jail-time of up to 20 years, according to <em>The Bali Sun</em>. </p> <p>“Indonesia is a country that upholds the tourism sector, but comfort must be accompanied by order. We want foreign nationals who come to Indonesia to understand and follow the rules and norms that apply in this country,” Director General of Immigration Law and Human Rights Silmy Karim said, according to local newspaper <em>Nusa Bali</em>.</p> <p>“We also try to ensure that those who come are quality tourists, through strengthening intelligence co-operation and information exchange with other countries.”</p> <p>There will also be an increase in immigration checkpoint officers, patrol officers and investigators, and more mobile taskforces. </p> <p>The rules won't affect tourists who apply for temporary visas on arrival and leave with in the mandated 30-day period or extend their visa and leave within 60 days. </p> <p>The Indonesian government has recently cracked down on foreigners overstaying their welcome, deporting more than 400 people this year alone for violating immigration laws. </p> <p>Just last year, a dozen Australians were among more than 200 foreigners kicked out of Bali for abusing the visa system by doing illegal business or working in Bali. </p> <p>This follows the introduction of the tourist tax and the release of their tourist dos and don'ts list, as they attempt to monitor foreigners' activities. </p> <p><em>Image: </em><em>AsiaTravel / Shutterstock.com</em></p> <p> </p>

Legal

Placeholder Content Image

New study finds epilepsy drug could reduce sleep apnoea symptoms

<p>New research has found that a drug used for epilepsy could be used to reduce the symptoms of sleep apnoea. </p> <p>Obstructive sleep apnoea, which affects about one in 20 people, according to the National Institute for Health and Care Excellence in England, includes symptoms like snoring and it causes a person's breathing to start and stop during the night, with many requiring an aid to help keep their airways open. </p> <p>An international study has identified that taking sulthiame, a drug sold under the brand name Ospolot in Europe, may help prevent patients' breathing from temporarily stopping. </p> <p>This provides an additional option for those unable to use mechanical breathing aids like the Cpap machines. </p> <p>“The standard treatment for obstructive sleep apnoea is sleeping with a machine that blows air through a face mask to keep the airways open. Unfortunately, many people find these machines hard to use over the long term, so there is a need to find alternative treatments,” Prof Jan Hedner from Sahlgrenska university hospital and the University of Gothenburg in Sweden said. </p> <p>Researchers conducted a randomised controlled trial of almost 300 obstructive sleep apnoea patients across Europe, who did not use Cpap machines. </p> <p>They were divided into four groups and given either a placebo or different strengths of sulthiame. </p> <p>The study measured patients’ breathing, oxygen levels, heart rhythm, eye movements, as well as brain and muscle activity while asleep. </p> <p>It found after 12 weeks, those taking sulthiame had up to 50% fewer occasions where their breathing stopped, and higher levels of oxygen in their blood. However, a bigger study needs to be done to confirm the beneficial effects on a larger group. </p> <p>The findings, were presented at the European Respiratory Society Congress in Vienna, Austria. </p> <p>Erika Radford, the head of health advice at Asthma + Lung UK said the findings were a positive step forward in moving away from having to rely on mechanical breathing equipment.</p> <p>“This potential alternative to the current main treatment would make it easier for people to manage their condition,” she said. </p> <p><em>Image: Shutterstock</em></p>

Body

Placeholder Content Image

Common drug shows potential in reversing ageing

<p>A common medication has been found to have anti-ageing qualities, with scientists finding that the drug can de-age monkeys. </p> <p>Metformin, a cheap and common diabetes drug that has been used since the 1950s, could be an anti-ageing elixir, with scientists from the Chinese Academy of Sciences and Beijing Institute of Genomics using the pill to "markedly" slow down ageing in the animals.</p> <p>According to the experts, the medication reduced deterioration of the brain and boosted cognitive abilities in the primates while also slowing down bone loss and aiding in the "rejuvenation" of several tissues and organs. </p> <p>The most significant improvements were seen in the liver and frontal lobe, the part of the brain responsible for language, reasoning, problem solving, memory, movement and personality. </p> <p>Researchers said all of the findings led to the conclusion that "metformin can reduce biological age indicators" up to six years, with the medication paving the way for ageing reversal in humans.</p> <p>The drug was previously tested on mice, but since testing the medication on Cynomolgus monkeys - that are both physiologically and functionally similar to humans - the tests have shown more promise for potential human trials. </p> <p>The researchers said of the 40-month study, "Our research pioneers the systemic reduction of multi-dimensional biological age in primates through metformin, paving the way for advancing pharmaceutical strategies against human ageing."</p> <p>The scientists added, "[The study] represents an important advance in the quest to delay human ageing, with geriatric medicine research gradually shifting its focus from treating individual chronic diseases to systemic intervention against ageing."</p> <p><em>Image credits: Shutterstock </em></p>

Body

Placeholder Content Image

Tragic flaw sees man use voluntary assisted dying drugs prescribed for his wife

<p><strong><em>Warning: This article contains discussions of suicide and depression that some readers may find upsetting</em></strong></p> <p>A Queensland coroner has criticised the state's voluntary assisted dying laws, after an elderly man took his own life using drugs prescribed for his wife.</p> <p>The Coroner's Court in Brisbane held an inquest into the May 2023 death of a man in his 80s, referred to by the pseudonym ABC.</p> <p>The man's partner, who had a terminal illness, was found eligible for the voluntary assisted dying [VAD] program in March 2023. </p> <p>Under that law a person can self-administer a VAD substance in a private location but they must nominate a "contact person" who will be legally required to return any unused or leftover portion within 14 days.</p> <p>The self-administered drug was delivered to the couple's home a month later, and the man was the "contact person" responsible for the substance. </p> <p>On the same day the drug arrived, his wife was admitted to hospital with Covid, where they decided to take an intravenous VAD drug. She died in hospital on May 8, 2023.</p> <p>The man was told to return the drug within two days of his partner's death, but he failed to do so, using it to take his own life eight days later. </p> <p>He did not return the drug as he was unable to leave his home, and there was no arrangement made for a health professional to collect it. </p> <p>ABC’s adult daughter recalled the moment she found her lifeless father after returning from running errands. </p> <p>“I thought he was asleep in the chair. I put my arms around him. He was cold,” she told the inquest. </p> <p>The woman became emotional and said that she found an empty box in the kitchen and “knew immediately it was the VAD”.</p> <p>In his findings, coroner David O’Connell said he was not judging the merits of VAD, but it had led to a "tragedy" only 107 days after it was legalised. </p> <p>“Persons should not be placed in a position where they can be led into unwise decisions,” the coroner said in his findings handed down on Wednesday.</p> <p>O'Connell said that the laws had failed to find a balance between a patient's autonomy and lethal medication safety. </p> <p>“The VAD law has (the substance) provided to persons with no medical training, no regulatory oversight, and in a period of great personal and emotional turmoil,” he said.</p> <p>The inquest heard ABC had previously been diagnosed with, and received medication for depression, which should've been considered before approving someone as a contact person. </p> <p>"The fact that ABC had been medically diagnosed with depression and took medication was not something the VAD authorities considered, or even enquired on, when approving them to be a Contact Person. Indeed, there are simply no checks or enquiries of the Contact Person's suitability," he said. </p> <p>He added that while there was no breach of protocol or legislative processes by QVAD personnel, it was "not a well-considered law".</p> <p>O'Connell recommended the Queensland government implement an earlier draft of VAD laws that required oversight by a medical professional at all times.</p> <p>Queensland Health Minister Shannon Fentiman said the government would consider the coroner’s recommendations. </p> <p>“Following that case, we are working on a review of that legislation coming up to three years that will start next year, and that will obviously be one of the things that we look at,” she said.</p> <p><em>Image: Shutterstock</em></p>

Caring

Placeholder Content Image

Kyle Sandilands' warning about new "right to disconnect" laws

<p>Kyle Sandilands has warned Aussies against "abusing the system" put in place by new 'right to disconnect' laws. </p> <p>As of August 26th, employees of large companies can legally refuse to respond to "unreasonable" after-hours calls from their employer.</p> <p>Discussing the new laws on KIIS FM on Monday morning, Sandilands warned workers about celebrating the laws too soon, as they could come with a catch depending on the leniency of employers. </p> <p>"It doesn't mean they won't railroad you out behind the scenes," the radio host said.</p> <p>Kyle then argued that while it would be illegal under the new legislation for bosses to punish workers for not responding after hours, some devious managers could find ways around the laws.</p> <p>"Don't think for a second: 'Screw that real estate agent boss'," Kyle said. "Because eventually they will find a way to get rid of you to work around the boundaries."</p> <p>Sandilands then urged Aussies not to "abuse the system", saying, "Everyone you can say, 'oh by law, I don't have to respond to that' and they will then go, 'no worries'."</p> <p>"And then they get you for every little tiny infringement. You will go if they want you to go, one way or another. So, don't abuse the system."</p> <p>Jackie O then chimed in on the debate, saying the laws were a direct response to a modern working problem. </p> <p>"I feel like that might happen," Jackie said.</p> <p>"I think it's sometimes because the thing is that work hours now are infinity. When you didn't have email and mobile phones, you never got bothered outside of work hours."</p> <p>Kyle replied, "And nothing got done. It was the late 1970s. The world spun very slowly back then."</p> <p><em>Image credits: KIIS FM</em></p>

Legal

Placeholder Content Image

Aussie Olympian arrested in Paris after trying to buy drugs

<p>An Aussie Olympian has been arrested after he was caught on the streets of Paris trying to buy a gram of cocaine. </p> <p>Hockey superstar Tom Craig tried to outrun police when he was caught, before realising he couldn't evade the authorities and surrendered. </p> <p>He and teammates had been at a family and friends celebration at the Hotel Maison in Montmartre in the 9th arrondissement after both his team and the Hockeyroos team of girlfriend Alice Arnott lost in the quarter finals.</p> <p>The 28-year-old had spent nearly 18 hours in custody after being arrested at midnight on Tuesday before being released with “a probationary criminal warning for drug use”.</p> <p>As a result of his indiscretion, the Kookaburras veteran has had his Olympic rights stripped from him, been banned from the athletes village and told he does not have the right to march in the closing ceremony.</p> <p>Craig, who is a qualified solicitor, fronted the media in central Paris hours before an AOC press conference, in which he apologised for his behaviour.</p> <p>“I would firstly like to apologise for what has occurred over the last 24 hours,” the Tokyo silver medallist said. “I made a terrible mistake and I take full responsibility for my actions."</p> <p>“My actions are my own and by no way reflect the values of my family, my teammates, my friends, the sport and the Australian Olympic team. I have embarrassed you all and I’m truly sorry.” </p> <p>In the AOC press conference, Australian Olympic chef de mission Anna Meares said she was adamant Kookaburras star Tom Craig was acting alone when trying to purchase the drugs. </p> <p>“We do feel very confident that this is an isolated incident,” Meares said.</p> <p>“I would rather be here talking about the three gold medals that we have won today. But here we are first."</p> <p>“I cannot condone what Tom has done. He is a good person who made a bad decision. But there are consequences that come with decisions like this."</p> <p>“Our team has been exemplary at these Games and his actions do not reflect the values of this team, nor do they diminish this team’s performances. He has apologised, shown remorse and he has owned up to his mistake and we will support him if he needs help."</p> <p><em>Image credits: X (Twitter)/DAVE HUNT/EPA-EFE/Shutterstock Editorial </em></p>

Legal

Placeholder Content Image

“Don’t marry him”: Bride-to-be shares wild altercation with her future in-laws over her wedding dress

<p dir="ltr">A woman has been told to “run” from her fiancé after sharing a wild conversation she had with her future in-laws about her wedding dress. </p> <p dir="ltr">The bride-to-be shared that ever since she was a child, she wanted to wear her mother’s wedding dress on her own big day. </p> <p dir="ltr">However, the woman was then confronted by her soon-to-be in-laws, with drama ensuing over her wedding dress.</p> <p dir="ltr">Taking to Reddit’s “Am I The A**hole?” page, the woman explained, "My mother's wedding dress has been passed down for generations and I remember being a little girl dreaming of walking down the aisle in it."</p> <p dir="ltr">Despite her wishes to wear the family heirloom on her big day, she said things went south at a dinner at her sister-in-law’s (SIL) house when she  "tapped her spoon against the glass and said that she had to make a toast."</p> <p dir="ltr">"She then said she would be right back before going into another room and returning with a large plastic bag," the bride continues.</p> <p dir="ltr">"Everyone seemed to be excited but I just felt confused."</p> <p dir="ltr">As she "awkwardly smiled", her SIL opened the bag to reveal her wedding dress from her wedding two years earlier as her in-laws began clapping, as her future sister-in-law announced she wanted the bride to wear her dress at her upcoming nuptials.</p> <p dir="ltr">"I tried to smile but I guess I didn't do a good job of hiding my disappointment and everyone began asking me what was wrong," the bride-to-be continues, adding that she tried to explain that she wanted to wear her mother's wedding dress.</p> <p dir="ltr">At this point, her SIL began to cry and her in-laws began berating her, causing the bride to burst into tears and run outside.</p> <p dir="ltr">"My fiancé didn't even come after me and after crying my eyes out on the steps for what felt like hours, he finally came outside and yelled at me to get into the car," she says.</p> <p dir="ltr">Confused, she got into the car only for her fiancé to berate her for making "such a big scene" leaving him feeling "embarrassed in front of his family."</p> <p dir="ltr">"He sounds so mad and he even said he couldn't believe he chose to marry such a 'bitchy c--t' (his exact words)."</p> <p dir="ltr">The woman tried to explain how important it was to her to wear her mother's dress and that she had already promised her mother she would be wearing it on her big day.</p> <p dir="ltr">"I felt like my fiancé's family planned this and put me on the spot thinking I wouldn't stand up for myself and just agree to wear SIL's dress," she continues.</p> <p dir="ltr">"I don't think I did anything wrong but a part of me thinks I should have just gone along with it and then told SIL in private that I wouldn't be wearing the dress."</p> <p dir="ltr">Hundreds of people were quick to comment on her post, suggesting that she “run” not only from her in-laws, but from her partner as well. </p> <p dir="ltr">"Ma'am you need to leave that whole family behind including your fiancé," one said. "You just had a peek into your future if you carry on with this relationship."</p> <p dir="ltr">"Don't you dare marry that man!!!" another said.</p> <p dir="ltr">"The problem doesn't exist as the wedding shouldn't be happening anymore," another added.</p> <p dir="ltr">One Redditor suggested she "be thankful that he is showing you who he really is before you marry him."</p> <p dir="ltr">"You have just had a glimpse of what your future is going to look like if you go through with your wedding."</p> <p dir="ltr"><em>Image credits: Shutterstock </em></p> <p> </p>

Family & Pets

Placeholder Content Image

Worried your address, birth date or health data is being sold? You should be – and the law isn’t protecting you

<div class="theconversation-article-body"><em><a href="https://theconversation.com/profiles/katharine-kemp-402096">Katharine Kemp</a>, <a href="https://theconversation.com/institutions/unsw-sydney-1414">UNSW Sydney</a></em></p> <p>Australians don’t know and can’t control how data brokers are spreading their personal information. This is the core finding of a newly <a href="https://www.accc.gov.au/system/files/Digital-platform-services-inquiry-March-2024-interim-report.pdf">released report</a> from the Australian Competition and Consumer Commission (ACCC).</p> <p>Consumers wanting to rent a property, get an insurance quote or shop online are not given real choices about whether their personal data is shared for other purposes. This exposes Australians to scams, fraud, manipulation and discrimination.</p> <p>In fact, <a href="https://www.accc.gov.au/media-release/consumers-lack-visibility-and-choice-over-data-collection-practices">many don’t even know</a> what kind of data has been collected about them and shared or sold by data firms and other third parties.</p> <p>Our privacy laws are due for reform. But Australia’s privacy commissioner <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4224653">should also enforce</a> an existing rule: with very limited exceptions, businesses must not collect information about you from third parties.</p> <h2>What are data brokers?</h2> <p><a href="https://cprc.org.au/wp-content/uploads/2024/02/CPRC-Singled-Out-Final-Feb-2024.pdf">Data brokers</a> generally make their profits by collecting information about individuals from various sources and sharing this personal data with their many business clients. This can include detailed profiles of a person’s family, health, finances and movements.</p> <p>Data brokers often have no connection with the individual – you may not even recognise the name of a firm that holds vast amounts of information on you. Some of these data brokers are large multinational companies with billions of dollars in revenue.</p> <p>Consumer and privacy advocates provided the ACCC with evidence of highly concerning data broker practices. <a href="https://www.accc.gov.au/system/files/Salinger%20Privacy.pdf">One woman</a> tried to find out how data brokers had got hold of her information after receiving targeted medical advertising.</p> <p>Although she never discovered how they obtained her data, she found out it included her name, date of birth and contact details. It also included inferences about her, such as her retiree status, having no children, not having “high affluence” and being likely to donate to a charity.</p> <p>ACCC found another data broker was reportedly creating lists of individuals who may be experiencing vulnerability. The categories included:</p> <ul> <li>children, teenage girls and teenage boys</li> <li>“financially unsavvy” people</li> <li>elderly people living alone</li> <li>new migrants</li> <li>religious minorities</li> <li>unemployed people</li> <li>people in financial distress</li> <li>new migrants</li> <li>people experiencing pain or who have visited certain medical facilities.</li> </ul> <p>These are all potential vulnerabilities that could be exploited, for example, by scammers or unscrupulous advertisers.</p> <h2>How do they get this information?</h2> <p>The ACCC notes <a href="https://cprc.org.au/wp-content/uploads/2023/03/CPRC-working-paper-Not-a-fair-trade-March-2025.pdf">74% of Australians are uncomfortable</a> with their personal information being shared or sold.</p> <p>Nonetheless, data brokers sell and share Australian consumers’ personal information every day. Businesses we deal with – for example, when we buy a car or search for natural remedies on an online marketplace – both buy data about us from data brokers and provide them with more.</p> <p>The ACCC acknowledges consumers haven’t been given a choice about this.</p> <p>Attempting to read every privacy term is near impossible. The ACCC referred to a recent study which found it would take consumers <a href="https://www.mi-3.com.au/06-11-2023/aussies-face-10-hour-privacy-policy-marathon-finds-study">over 46 hours a month</a> to read every privacy policy they encounter.</p> <figure class="align-center zoomable"><a href="https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=45&amp;auto=format&amp;w=1000&amp;fit=clip"><img src="https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=45&amp;auto=format&amp;w=754&amp;fit=clip" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px" srcset="https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=45&amp;auto=format&amp;w=600&amp;h=131&amp;fit=crop&amp;dpr=1 600w, https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=30&amp;auto=format&amp;w=600&amp;h=131&amp;fit=crop&amp;dpr=2 1200w, https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=15&amp;auto=format&amp;w=600&amp;h=131&amp;fit=crop&amp;dpr=3 1800w, https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=45&amp;auto=format&amp;w=754&amp;h=165&amp;fit=crop&amp;dpr=1 754w, https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=30&amp;auto=format&amp;w=754&amp;h=165&amp;fit=crop&amp;dpr=2 1508w, https://images.theconversation.com/files/595623/original/file-20240522-23-2zkuc.png?ixlib=rb-4.1.0&amp;q=15&amp;auto=format&amp;w=754&amp;h=165&amp;fit=crop&amp;dpr=3 2262w" alt="" /></a><figcaption><span class="caption">The approximate length and time it would take to read an average privacy policy in Australia per month.</span> <span class="attribution"><a class="source" href="https://www.accc.gov.au/about-us/publications/serial-publications/digital-platform-services-inquiry-2020-25-reports/digital-platform-services-inquiry-interim-report-march-2024">ACCC Digital Platform Services Inquiry interim report</a></span></figcaption></figure> <p>Even if you could read every term, you still wouldn’t get a clear picture. Businesses use <a href="https://cprc.org.au/wp-content/uploads/2024/02/CPRC-Singled-Out-Final-Feb-2024.pdf">vague wording</a> and data descriptions which <a href="https://theconversation.com/70-of-australians-dont-feel-in-control-of-their-data-as-companies-hide-behind-meaningless-privacy-terms-224072">confuse consumers</a> and have no fixed meaning. These include “pseudonymised information”, “hashed email addresses”, “aggregated information” and “advertising ID”.</p> <p>Privacy terms are also presented on a “take it or leave it” basis, even for transactions like applying for a rental property or buying insurance.</p> <p>The ACCC pointed out 41% of Australians feel they have been <a href="https://www.choice.com.au/consumers-and-data/data-collection-and-use/how-your-data-is-used/articles/choice-renttech-report-release">pressured to use “rent tech” platforms</a>. These platforms collect an increasing range of information with questionable connection to renting.</p> <h2>A first for Australian consumers</h2> <p>This is the first time an Australian regulator has made an in-depth report on the consumer data practices of data brokers, which are generally hidden from consumers. It comes <a href="https://www.ftc.gov/system/files/documents/reports/data-brokers-call-transparency-accountability-report-federal-trade-commission-may-2014/140527databrokerreport.pdf">ten years after</a> the United States Federal Trade Commission (FTC) conducted a similar inquiry into data brokers in the US.</p> <p>The ACCC report examined the data practices of nine data brokers and other “data firms” operating in Australia. (It added the term “data firms” because some companies sharing data about people argue that they are not data brokers.)</p> <p>A big difference between the Australian and the US reports is that the FTC is both the consumer watchdog and the <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2312913">privacy regulator</a>. As our competition and consumer watchdog, the ACCC is meant to focus on competition and consumer issues.</p> <p>We also need our privacy regulator, the Office of the Australian Information Commissioner (OAIC), to pay attention to these findings.</p> <h2>There’s a law against that</h2> <p>The ACCC report shows many examples of businesses collecting personal information about us from third parties. For example, you may be a customer of a business that only has your name and email address. But that business can purchase “<a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4224653">data enrichment</a>” services from a data broker to find out your age range, income range and family situation.</p> <p>The <a href="https://www.legislation.gov.au/C2004A03712/latest/text">current Privacy Act</a> includes <a href="https://www.oaic.gov.au/privacy/australian-privacy-principles/read-the-australian-privacy-principles">a principle</a> that organisations must collect personal information only from the individual (you) unless it is unreasonable or impracticable to do so. “Impracticable” means practically impossible. This is the direct collection rule.</p> <p>Yet there is no reported case of the privacy commissioner enforcing the direct collection rule against a data broker or its business customers. Nor has the OAIC issued any specific guidance in this respect. It should do both.</p> <h2>Time to update our privacy laws</h2> <p>Our privacy law was drafted in 1988, long before this complex web of digital data practices emerged. Privacy laws in places such as California and the European Union provide much stronger protections.</p> <p>The government has <a href="https://ministers.ag.gov.au/media-centre/speeches/privacy-design-awards-2024-02-05-2024">announced</a> it plans to introduce a privacy law reform bill this August.</p> <p>The ACCC report reinforces the need for vital amendments, including a direct right of action for individuals and a rule requiring dealings in personal information to be “fair and reasonable”.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/230540/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em><a href="https://theconversation.com/profiles/katharine-kemp-402096">Katharine Kemp</a>, Associate Professor, Faculty of Law &amp; Justice, <a href="https://theconversation.com/institutions/unsw-sydney-1414">UNSW Sydney</a></em></p> <p><em>Image credits: Shutterstock</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/worried-your-address-birth-date-or-health-data-is-being-sold-you-should-be-and-the-law-isnt-protecting-you-230540">original article</a>.</em></p> </div>

Legal

Placeholder Content Image

Grieving dad fights for "ZaZa's Law" after toddler dies in his arms

<p>A grieving father has called for change after his toddler tragically died from choking on a grape. </p> <p>Brian Bwoga, a 44-year-old dad from Perth was at the beach with his two sons, Alessandro, four, and Zaire (ZaZa) 22 months, at the beginning of the year on what seemed like a normal family day out. </p> <p>But what was meant to be an idyllic summer’s day soon turned into any parent’s worst nightmare.</p> <p>“The weather was amazing, the boys were playing and it was just the perfect summer’s day,” Brian, who parents his boys with their mother Claudia, 39, told <a href="https://www.news.com.au/lifestyle/real-life/news-life/perth-toddler-dies-five-minutes-after-being-eating-popular-snack/news-story/0bfb598fe70bb5b47259cdc3b80c60cd" target="_blank" rel="noopener"><em>news.com.au</em></a>.</p> <p>“I was gathering up our things ready to go home. My older son Alex came up to me and asked if he could play for just five more minutes. I was carrying ZaZa, and I told them both to go and play together with their friends while I finish packing the car."</p> <p>“The next minute ZaZa is just running to me, holding his neck and gasping for air."</p> <p>“I jumped into action and did CPR, I put my fingers inside his throat and got one grape out. I was so relieved, I thought thank god I got it out. But I didn’t know there were four more grapes inside his throat.”</p> <p>The toddler continued to choke on the grapes, and Brian says his eyes started “popping out”.</p> <p>The terrified dad began performing abdominal thrusts to try and dislodge the grapes but to no avail.</p> <p>“I told one of the mothers to call the ambulance. I was terrified,” he recalled.</p> <p>“My older son was scared and asked me why there was blood coming from ZaZa’s mouth. I told him to go with another parent because I didn’t want him to see this. I was holding ZaZa and he was looking at me. I gave him CPR again and I tried so hard to save him."</p> <p>“He gave me this look and died in my arms.”</p> <p>“I left home with a beach bag and left with a body bag. It happened so quick. Within a few minutes he was gone. My son Alex is traumatised. He misses his brother so much and I don’t know how to fix it.”</p> <p>Grapes are a notorious choking hazard for children under the age of 5, as it is often recommended to always cut up grapes when feeding them to young kids.</p> <p>Sadly, Zaza consumed the grapes whole, and although the mistake cost his son his life, he doesn't place the blame on anyone.</p> <p>Instead, he wants to educate the public about the importance of cutting up grapes and is now fighting for <a href="https://www.change.org/p/zaza-s-law?source_location=petitions_browse" target="_blank" rel="noopener">change</a> as he hopes to introduce ‘ZaZa’s Law’ to parliament. </p> <p>This new law would ensure there are choking hazard labels on all grape packets and other food items that could be dangerous for small children.</p> <p>“I would hate for this to happen to anyone else. But I hear so many stories about kids dying from choking,” he said.</p> <p>“Ideally, I would like a warning label on all grapes and small foods to warn people to cut them up. Even a big sign at the supermarket for parents."</p> <p>“Not everyone knows this, but every parent needs to be aware of the dangers of food. I want ZaZa’s Law to come into parliament to get labels on everything."</p> <p>“We buy toys and they come with warning labels for things like batteries or other choking hazards. Why can’t we do the same for food?”</p> <p>The dad also hopes that a new anti-choking device, called LifeVac, might be more widely introduced in Australia and placed in public spaces.</p> <p>“Everywhere you go, shopping centres or beaches, there is a defibrillator on the wall,” he explained.</p> <p>“That is great, but we also need those anti-choking devices. It sucks everything up like a plunger and has saved so many lives."</p> <p>“If we had that at the beach that day, ZaZa might still be here.”</p> <p><em>Image credits: Courtesy of Brian Bwoga</em></p>

Caring

Our Partners